Breaking News
Upgrade 0
📈 💰 Our AI knew ViaSat had strong potential… now it's up +99.7%
Pick Stocks with AI
Close

Ubs Sdic Csi Gr Entpr Test (161223)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
UBS SDIC CSI Gr Entpr test historical data, for real-time data please try another search
1.714 -0.010    -0.35%
24/06 - Closed. Currency in CNY
Type:  Fund
Market:  China
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 20.69M
UBS SDIC CSI Gr Entpr test 1.714 -0.010 -0.35%

161223 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the UBS SDIC CSI Gr Entpr test (161223) fund. Our UBS SDIC CSI Gr Entpr test portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 6.510 6.510 0.000
Shares 94.170 94.170 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 17.504 13.987
Price to Book 4.882 1.772
Price to Sales 1.951 1.348
Price to Cash Flow 12.474 8.674
Dividend Yield 1.615 2.765
5 Years Earnings Growth 37.140 11.624

Sector Allocation

Name  Net % Category Average
Healthcare 27.670 7.789
Technology 23.810 15.910
Industrials 15.670 18.668
Basic Materials 12.770 10.243
Consumer Cyclical 11.210 10.189
Consumer Defensive 4.390 10.966
Communication Services 2.500 3.483
Real Estate 0.910 3.555
Energy 0.540 3.951
Utilities 0.530 4.807

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 103

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Luxshare Precision A CNE100000TP3 9.12 45.98 -0.26%
  Walvax BioTech CNE100000WN2 5.50 12.64 -0.86%
  Hangzhou Tigermed Consulting CNE100001KV8 4.58 63.51 -0.36%
  Shenzhen Kangtai Bio CNE100002Q33 3.92 18.71 -0.95%
  Chongqing Zhifei Bio Products CNE100000V20 3.22 22.51 -0.92%
  Wuxi Lead Auto Equipment Co Ltd CNE100001ZF9 3.08 35.51 +20.01%
  YUNDA Holding CNE100000015 2.89 7.99 -5.33%
  Yunnan Chuangxin New Material CNE100002BR3 2.63 32.30 +2.64%
  NanJi ECommerce CNE100000080 2.57 3.67 -0.81%
  Mango Excellent Media CNE100001Y83 2.42 26.08 +0.69%

Top Equity Funds by UBS SDIC Fund Mgmt Co.,Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  UBS SDIC State Security Alloc 4.27B 18.11 2.44 -
  UBS SDIC Ruili Alloc LOF 1.17B 3.99 -0.04 9.58
  UBS SDIC Core Enterprises Stock 777.77M 7.19 -4.45 1.29
  UBS SDIC Innovation Power Stock 770.22M 5.44 -8.84 3.34
  UBS SDIC Stategy Selected Balance 695.88M 8.11 -1.87 10.41
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

161223 Comments

Write your thoughts about Ubs Sdic Csi Gr Entpr Test
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email